EBS

Emergent Biosolutions (EBS)

Emergent Biosolutions Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:EBS
DateTimeSourceHeadlineSymbolCompany
11/14/20226:30AMGlobeNewswire Inc.Emergent BioSolutions Receives Department of Defense Award to Evaluate Chikungunya Vaccine Candidate in Post-Approval Field Efficacy Study Using Model-Guided Approach NYSE:EBSEmergent Biosolutions Inc
11/09/20226:08AMEdgar (US Regulatory)Quarterly Report (10-q) NYSE:EBSEmergent Biosolutions Inc
11/08/20224:53PMEdgar (US Regulatory)Current Report Filing (8-k) NYSE:EBSEmergent Biosolutions Inc
11/08/20224:16PMGlobeNewswire Inc.Emergent BioSolutions Reports Financial Results For Third Quarter 2022 NYSE:EBSEmergent Biosolutions Inc
11/01/20224:05PMGlobeNewswire Inc.Emergent BioSolutions Presents Data from Phase 2 Study Evaluating Safety and Immunogenicity of Chikungunya Vaccine Candidate in Prior Recipients of Other Alphavirus Vaccines NYSE:EBSEmergent Biosolutions Inc
10/27/20228:30AMGlobeNewswire Inc.SAB Biotherapeutics Announces Exclusive Manufacturing Partnership with Emergent BioSolutions NYSE:EBSEmergent Biosolutions Inc
10/18/20226:30AMGlobeNewswire Inc.Emergent BioSolutions to Release Third Quarter 2022 Financial Results and Conduct Conference Call on November 8, 2022 NYSE:EBSEmergent Biosolutions Inc
09/26/20225:06PMEdgar (US Regulatory)Current Report Filing (8-k) NYSE:EBSEmergent Biosolutions Inc
09/26/20224:12PMGlobeNewswire Inc.Emergent BioSolutions Completes Acquisition of Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages NYSE:EBSEmergent Biosolutions Inc
09/06/20226:30AMGlobeNewswire Inc.Emergent BioSolutions Initiates Phase 1 Study Evaluating Lassa Virus Vaccine Candidate NYSE:EBSEmergent Biosolutions Inc
08/12/20226:01PMDow Jones NewsFDA Issues Warning Letter to Emergent Biosolutions After February Inspection NYSE:EBSEmergent Biosolutions Inc
08/12/20225:04PMEdgar (US Regulatory)Current Report Filing (8-k) NYSE:EBSEmergent Biosolutions Inc
08/10/20226:30AMGlobeNewswire Inc.Emergent BioSolutions to Participate in Investor Conferences NYSE:EBSEmergent Biosolutions Inc
08/04/20228:12AMTipRanksJ.P. Morgan Reaffirms Their Hold Rating on Emergent Biosolutions (EBS) NYSE:EBSEmergent Biosolutions Inc
08/03/20226:02AMEdgar (US Regulatory)Amended Current Report Filing (8-k/a) NYSE:EBSEmergent Biosolutions Inc
08/02/20226:02AMEdgar (US Regulatory)Quarterly Report (10-q) NYSE:EBSEmergent Biosolutions Inc
08/01/20224:12PMEdgar (US Regulatory)Current Report Filing (8-k) NYSE:EBSEmergent Biosolutions Inc
08/01/20224:05PMGlobeNewswire Inc.Emergent BioSolutions Reports Financial Results for Second Quarter 2022 NYSE:EBSEmergent Biosolutions Inc
07/22/20224:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4) NYSE:EBSEmergent Biosolutions Inc
07/18/20224:05PMGlobeNewswire Inc.Emergent BioSolutions to Release Second Quarter 2022 Financial Results and Conduct Conference Call on August 1, 2022 NYSE:EBSEmergent Biosolutions Inc
07/07/20224:30PMGlobeNewswire Inc.Emergent BioSolutions and Ridgeback Biotherapeutics Enter Into Agreement for Ebanga™ Treatment for Ebola NYSE:EBSEmergent Biosolutions Inc
07/06/20224:05PMGlobeNewswire Inc.Emergent BioSolutions Announces Appointment of Sujata Dayal to Board of Directors NYSE:EBSEmergent Biosolutions Inc
06/24/20227:13AMDow Jones NewsEmergent BioSolutions: FDA to Review AV7909 Anthrax Vaccine Candidate NYSE:EBSEmergent Biosolutions Inc
06/24/20226:30AMGlobeNewswire Inc.Emergent BioSolutions Announces FDA Acceptance of Biologics License Application for AV7909 Anthrax Vaccine Candidate NYSE:EBSEmergent Biosolutions Inc
06/21/20226:30AMGlobeNewswire Inc.Emergent BioSolutions Announces Publication of CHIKV VLP Phase 2 Safety and Immunogenicity Data in The Lancet Infectious Diseases NYSE:EBSEmergent Biosolutions Inc
06/13/20224:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4) NYSE:EBSEmergent Biosolutions Inc
06/07/20226:44AMEdgar (US Regulatory)Current Report Filing (8-k) NYSE:EBSEmergent Biosolutions Inc
06/06/20229:17AMDow Jones NewsEmergent BioSolutions Says Janssen Has Breached Covid Vaccine Contract NYSE:EBSEmergent Biosolutions Inc
06/06/20228:03AMEdgar (US Regulatory)Current Report Filing (8-k) NYSE:EBSEmergent Biosolutions Inc
06/02/20228:20AMGlobeNewswire Inc.Emergent BioSolutions to Participate in Investor Conferences NYSE:EBSEmergent Biosolutions Inc
 Showing the most relevant articles for your search:NYSE:EBS
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20221202 23:59:40